Gsa Capital Partners LLP Adamis Pharmaceuticals Corp Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$0.54 - $1.79 $278,749 - $924,003	-516,203 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$0.4 - $1.01 $184,180 - $465,055	460,451 Added 825.89%	516,203 $250,000
Q3 2020 Nov 06, 2020	BUY	$0.52 - $1.45 $28,991 - $80,840	55,752 New	55,752 $44,000
Q4 2019 Feb 12, 2020	SELL	$0.51 - $1.26 $14,258 - $35,227	-27,958 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.7 - $1.46 $78,152 - $163,004	-111,647 Reduced 79.97%	27,958 $20,000
Q2 2019 Aug 06, 2019	BUY	$1.26 - $2.23 $175,902 - $311,319	139,605 New	139,605 $181,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.